Among them, the GPSM2 phosphorylation level at the S408 site in glioblastoma multiforme (GLMU) PAADand KIRC and the S565 site in HNSC were significantly increased (Figure 6B, Figure 6C). This evidence concerns the gene GPSM2 and glioblastoma.